Keyan Wu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Pancreatitis Pathology and Treatment
Papers in
- Surgery 14
- Pancreatitis Pathology and Treatment 12
-
- Inflammasome and immune disorders 2
- Phytochemical Studies and Bioactivities 2
- Co-authors
- Yanbing Ding (22 shared papers)Weiming Xiao (19 shared papers)Guotao Lu (17 shared papers)Weijuan Gong (15 shared papers)Bin Deng (7 shared papers)Jian Wu (6 shared papers)Qingtian Zhu (8 shared papers)Dan Wang (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Gene (1 paper)BioMed Research International (1 paper)International Journal of Medical Informatics (1 paper)Lipids in Health and Disease (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Keyan Wu
34 papers receiving 561 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 70
- Surgery 159
- Oncology 89
- Immunology 71
- Immunology and Allergy 19
Countries citing papers authored by Keyan Wu
This map shows the geographic impact of Keyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyan Wu more than expected).
Fields of papers citing papers by Keyan Wu
This network shows the impact of papers produced by Keyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyan Wu. The network helps show where Keyan Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Keyan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 76 | |
| 2 | 2021 | 58 | |
| 3 | 2018 | 33 | |
| 4 | 2020 | 31 | |
| 5 | 2020 | 31 | |
| 6 | 2018 | 30 | |
| 7 | Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells. | 2019 | 26 |
| 8 | 2014 | 25 | |
| 9 | 2013 | 23 | |
| 10 | 2019 | 22 | |
| 11 | 2015 | 22 | |
| 12 | 2022 | 20 | |
| 13 | 2016 | 16 | |
| 14 | 2021 | 15 | |
| 15 | 2020 | 15 | |
| 16 | 2020 | 15 | |
| 17 | 2019 | 15 | |
| 18 | Transcribed ultraconserved noncoding RNA uc.160 acts as a negative regulator in gastric cancer. | 2018 | 14 |
| 19 | 2022 | 10 | |
| 20 | 2020 | 10 |
About Keyan Wu
Keyan Wu is a scholar working on Surgery, Molecular Biology, Cell Biology, Immunology and Oncology, having authored 37 papers that have together received 567 indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (12 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Inflammation biomarkers and pathways (2 papers), Flavonoids in Medical Research (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Inflammasome and immune disorders (2 papers) and Phytochemical Studies and Bioactivities (2 papers). The work is most often cited by research in Cancer Research (70 citations), Surgery (159 citations), Oncology (89 citations), Immunology (71 citations) and Immunology and Allergy (19 citations). Keyan Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yanbing Ding, Weiming Xiao, Guotao Lu, Weijuan Gong, Bin Deng, Jian Wu, Qingtian Zhu, Dan Wang, Weiwei Chen and Liang‐Hao Hu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Gene, BioMed Research International, International Journal of Medical Informatics and Lipids in Health and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.